FDA won petition to have ruling reconsidered

Share this content:
The FDA has won a petition to have the US Court of Appeals for the District of Columbia reconsider a ruling that mentally competent terminally ill patients should have access to post-Phase I investigational drugs if there are no government-approved alternatives.

Share this content:
Scroll down to see the next article